Cement Your Position as the First Choice for Molecular Glue Drug Developers
The molecular glue field are seeking trusted solution providers for support as they progress their glue pipelines from discovery into preclinical and clinical stages
The 3rd Molecular Glue Drug Development Summit was your golden opportunity to connect with the industry leaders from pharma, biotech and academia and demonstrate your bespoke services in screening for molecular glues, protein analysis, medical chemistry and synthesis, and animal models.
Interested in partnering in 2026? Get in touch with us at sponsor@hansonwade.com.
Our 2025 Partners:
Why Partner With Us?
Showcase Your Services
Take this opportunity to connect with the molecular glue community and demonstrate your valuable and unique services across experimental and virtual screening, protein analysis, and medicinal chemistry synthesis to assist biopharma in developing the most effective glue possible.
Connect with Industry Trailblazers
Meet and bond with the KOLs in the molecular glue space such as Novartis, GSK, Asha Therapeutics and more to develop meaningful connections.
Stay Informed with the Market Trends
As the molecular glue community continues to thrive and expand with non-degrading glues and novel ligases, keep up to date with the biopharma deals and the latest news in the space.
Companies In The Room Included:
SENIORITY OF ATTENDEES
TYPES OF COMPANIES ATTENDING
*Statistics takes from 2nd Molecular Glue Drug Development Summit 2024
Get in touch now to learn more about the custom packages available to you to showcase your company’s unique services.